Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Chu Lin MD

Chu Lin MD

Physician, Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China

Dr. Lin started his 8-year Medical Doctor program in Peking University Health Science Center (PKUHSC) in 2013. He received his doctoral training in Peking University People's Hospital, when he chose Endocrinology as his specialty. He was awarded a doctorate degree in Internal Medicine in 2021. After graduation, he has worked as an Endocrinologist in Peking University People’s Hospital. He is dedicated to the researches focusing on anti-diabetic medications and clinical management of diabetes complications. He now owns over 20 publications as first author or co-first author. He is also active in international conferences like ADA scientific sessions, IDF and AASD for academic communications.

Disclosures

Chu Lin has no conflict of interest to declare.

Recent Contributions to PracticeUpdate:

  1. Effect of SGLT2 Inhibitor Use on Amputation Risk Across Categories of Baseline Cardiovascular Disease and Diuretics Use in Patients With Type 2 Diabetes

Most Read This Week

Recently Updated